Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3854
-0.0050 (-1.28%)
At close: Apr 14, 2026
Market Cap784.45M +49.2%
Revenue (ttm)n/a
Net Income-80.20M
EPS-0.04
Shares Out2.01B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,002,449
Average Volume12,018,914
Open0.3902
Previous Close0.3904
Day's Range0.3756 - 0.3992
52-Week Range0.2570 - 1.1800
Beta1.15
RSI50.67
Earnings DateApr 30, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Sector Healthcare
Founded 2015
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements